Feature | July 18, 2014

Federal Dense Breast Tissue Inform Bill Introduced in Congress

Legislation empowers women to make informed healthcare decisions

dense breast inform, dense breasts

Dense breast tissue, as seen in this mammogram, can mask cancer lesions.

July 18, 2014 — A bill introduced in the U.S. House and Senate July 17, the Breast Density and Mammography Reporting Act, would improve breast cancer detection by requiring mammogram reports to include whether a woman has dense tissue. This information could be used so patients can discuss options with their doctors if they choose to seek additional breast cancer screening. 

Women with dense breast tissue may receive normal mammogram reports even if cancer is present because dense tissue can obscure cancer. Currently, there is no federal standard requiring women to be informed if they have dense tissue.

The bill would set a minimum federal standard, as designated by the Secretary of Health and Human Services (HHS), for notification and recommend women discuss with their doctors whether additional screening is necessary. The bill also directs HHS to study improved screening options for women with dense tissue.
 
Several states have developed their own versions of dense breast tissue inform laws, requiring mammograms to explain to their patient that they have dense breast tissue, which can reduce the ability of mammograms to detect cancer. Other options for breast imaging are available, which can help detect breast cancer, even in women with dense breast tissue. However, each varies in what it requires. There have been calls from women’s health advocates for a federal law so all states are on the same page.
 
The legislation was introduced in the Senate by Senators Dianne Feinstein (D-Calif.) and Kelly Ayotte (R-N.H.). Reps. Rosa DeLauro (D-Conn.) and Steve Israel (N.Y.) introduced similar legislation in the House of Representatives.
 
“Early detection of breast cancer is key to survival, and women must be given every available resource to make informed health care decisions,” said Senator Feinstein. “By requiring that patients be informed if they have dense tissue, this bill allows women to make potentially lifesaving choices about their care.”
“Preventative screenings are critically important to early detection of breast cancer, and they help save lives,” Ayotte said. “It’s also important that women have the information they need to be able to make informed decisions about their health care, and our bipartisan bill would ensure that women are informed about their relative breast density after a mammogram – giving them the option to discuss additional screenings and tests with their doctor.”
 
Approximately 40 percent of women have breast tissue categorized as dense, meaning relatively little fat and more connective and glandular tissue. Dense tissue can compromise the effectiveness of a mammogram and has also been cited as an independent risk factor for the development of breast cancer. As the American Cancer Society notes in Breast Cancer Facts and Figures, 2013-2014, “The risk of breast cancer increases with increasing breast density; women with very high density have a four to six fold increased risk of breast cancer compared to women with the least dense breasts.”
 
Breast density is also a topic of increasing awareness outside of the United States. Canada has introduced bill C-314, an act respecting the awareness of screening among women with dense breast tissue, and the U.K. has seen the emergence of a patient advocacy campaign.
 
There are now 19 states with their own versions of breast inform laws, including Massachusetts, Connecticut, Texas, Virginia, New York, California, Hawaii, Maryland, Tennessee, Alabama,  Nevada, Oregon, North Carolina, Pennsylvania, New Jersey, Arizona, Minnesota, Rhode Island and Missouri.
 
The Breast Density Mammography and Reporting Act is supported by the American Cancer Society Cancer Action Network, Breast Cancer Fund, Susan G. Komen and Are You Dense Advocacy.
 
According to the Centers for Disease Control and Prevention, breast cancer is the leading cause of cancer deaths for Hispanic women and the second-leading cause of cancer deaths for white, black, Asian/pacific islander and American indian/Alaska native women.
 
 

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init